JP2024050597A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024050597A5 JP2024050597A5 JP2024001947A JP2024001947A JP2024050597A5 JP 2024050597 A5 JP2024050597 A5 JP 2024050597A5 JP 2024001947 A JP2024001947 A JP 2024001947A JP 2024001947 A JP2024001947 A JP 2024001947A JP 2024050597 A5 JP2024050597 A5 JP 2024050597A5
- Authority
- JP
- Japan
- Prior art keywords
- hla
- gene
- genes
- hypoimmunogenic
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862698973P | 2018-07-17 | 2018-07-17 | |
| US201862698984P | 2018-07-17 | 2018-07-17 | |
| US201862698978P | 2018-07-17 | 2018-07-17 | |
| US201862698981P | 2018-07-17 | 2018-07-17 | |
| US201862698965P | 2018-07-17 | 2018-07-17 | |
| US62/698,981 | 2018-07-17 | ||
| US62/698,973 | 2018-07-17 | ||
| US62/698,984 | 2018-07-17 | ||
| US62/698,965 | 2018-07-17 | ||
| US62/698,978 | 2018-07-17 | ||
| PCT/US2019/042117 WO2020018615A2 (en) | 2018-07-17 | 2019-07-17 | Cells differentiated from immunoengineered pluripotent cells |
| JP2021502525A JP2021530232A (ja) | 2018-07-17 | 2019-07-17 | 免疫改変された多能性細胞から分化させた細胞 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502525A Division JP2021530232A (ja) | 2018-07-17 | 2019-07-17 | 免疫改変された多能性細胞から分化させた細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024050597A JP2024050597A (ja) | 2024-04-10 |
| JP2024050597A5 true JP2024050597A5 (enExample) | 2024-05-31 |
Family
ID=69165113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502525A Pending JP2021530232A (ja) | 2018-07-17 | 2019-07-17 | 免疫改変された多能性細胞から分化させた細胞 |
| JP2024001947A Pending JP2024050597A (ja) | 2018-07-17 | 2024-01-10 | 免疫改変された多能性細胞から分化させた細胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021502525A Pending JP2021530232A (ja) | 2018-07-17 | 2019-07-17 | 免疫改変された多能性細胞から分化させた細胞 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20210292715A1 (enExample) |
| EP (1) | EP3824074A4 (enExample) |
| JP (2) | JP2021530232A (enExample) |
| KR (1) | KR20210032454A (enExample) |
| CN (2) | CN112639079A (enExample) |
| AU (2) | AU2019305585A1 (enExample) |
| BR (1) | BR112021000637A2 (enExample) |
| CA (1) | CA3109078A1 (enExample) |
| IL (2) | IL314721A (enExample) |
| MX (2) | MX2021000614A (enExample) |
| SG (1) | SG11202100157YA (enExample) |
| WO (1) | WO2020018615A2 (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7016185B2 (ja) * | 2018-03-28 | 2022-02-04 | 国立大学法人大阪大学 | 幹細胞由来涙腺組織の作製方法 |
| EP3824074A4 (en) * | 2018-07-17 | 2022-04-20 | The Regents of The University of California | Cells differentiated from immunoengineered pluripotent cells |
| US11162079B2 (en) | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
| EP3966316A4 (en) | 2019-05-10 | 2023-01-25 | The Regents of The University of California | MODIFIED PLURIPOTENT CELLS |
| GB2584664B (en) * | 2019-06-10 | 2023-05-24 | Newcells Biotech Ltd | Improved retinal organoids and methods of making the same |
| JP7728747B2 (ja) | 2019-08-23 | 2025-08-25 | サナ バイオテクノロジー，インコーポレイテッド | Ｃｄ２４発現細胞およびそれらの用途 |
| WO2021146222A1 (en) * | 2020-01-13 | 2021-07-22 | Sana Biotechnology, Inc. | Modification of blood type antigens |
| WO2021146471A2 (en) * | 2020-01-15 | 2021-07-22 | The Regents Of The University Of California | Transplanted cell protection via inhibition of polymorphonuclear cells |
| CN115768446A (zh) * | 2020-03-25 | 2023-03-07 | 萨那生物技术股份有限公司 | 用于治疗神经病症和疾患的低免疫原性神经细胞 |
| CA3176644A1 (en) * | 2020-04-27 | 2021-11-04 | Sonja SCHREPFER | Repeat dosing of hypoimmunogenic cells |
| WO2021231712A1 (en) * | 2020-05-15 | 2021-11-18 | Rxcell Inc. | Hypoimmunogenic cells and uses thereof in immune responses |
| EP4196568A1 (en) | 2020-08-13 | 2023-06-21 | Sana Biotechnology, Inc. | Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions |
| US11591381B2 (en) | 2020-11-30 | 2023-02-28 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| CN116829698A (zh) * | 2020-12-07 | 2023-09-29 | 加利福尼亚大学董事会 | 通过SIRP-α衔接体的先天免疫细胞沉默 |
| US11473060B2 (en) | 2020-12-30 | 2022-10-18 | Crispr Therapeutics Ag | Compositions and methods for differentiating stem cells into NK cells |
| US11965022B2 (en) | 2020-12-31 | 2024-04-23 | Sana Biotechnology, Inc. | Methods and compositions for modulating CAR-T activity |
| CA3212370A1 (en) | 2021-03-03 | 2022-09-09 | Sana Biotechnology, Inc. | Immunosuppressive therapies for use with cardiomyocyte cell therapies, and associated methods and compositions |
| IL308097A (en) | 2021-05-27 | 2023-12-01 | Sana Biotechnology Inc | Hypoimmunogenic cells comprising engineered hla-e or hla-g |
| AU2022309875A1 (en) | 2021-07-14 | 2024-01-25 | Sana Biotechnology, Inc. | Altered expression of y chromosome-linked antigens in hypoimmunogenic cells |
| JP2024534771A (ja) | 2021-08-11 | 2024-09-26 | サナ バイオテクノロジー，インコーポレイテッド | 補体媒介性炎症反応を低減するための同種異系細胞療法のための遺伝子改変細胞 |
| MX2024001208A (es) | 2021-08-11 | 2024-04-22 | Sana Biotechnology Inc | Celulas primarias geneticamente modificadas para terapia celular alogenica. |
| JP2024532772A (ja) | 2021-08-11 | 2024-09-10 | サナ バイオテクノロジー，インコーポレイテッド | 低免疫原性細胞における遺伝子発現を変化させるための誘導性システム |
| WO2023019225A2 (en) | 2021-08-11 | 2023-02-16 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions |
| AU2022326565A1 (en) | 2021-08-11 | 2024-02-08 | Sana Biotechnology, Inc. | Genetically modified cells for allogeneic cell therapy |
| WO2023039588A1 (en) * | 2021-09-13 | 2023-03-16 | FUJIFILM Cellular Dynamics, Inc. | Methods for the production of committed cardiac progenitor cells |
| US20240400996A1 (en) * | 2021-09-23 | 2024-12-05 | The University Of Jordan | Dental pluripotent stem cells |
| CN115873797B (zh) * | 2021-09-29 | 2024-08-13 | 北京干细胞与再生医学研究院 | 一种视网膜色素上皮细胞的扩增培养基及培养方法 |
| WO2023069480A1 (en) * | 2021-10-20 | 2023-04-27 | Vascugen, Inc. | Hypoimmune vasculogenic cells |
| AU2022422147A1 (en) | 2021-12-23 | 2024-07-04 | Sana Biotechnology, Inc. | Chimeric antigen receptor (car) t cells for treating autoimmune disease and associated methods |
| EP4463171A2 (en) * | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Hypoimmune beta cells differentiated from pluripotent stem cells and related uses and methods |
| US20250302953A1 (en) | 2022-02-14 | 2025-10-02 | Sana Biotechnology, Inc. | Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells |
| AU2023220128A1 (en) | 2022-02-17 | 2024-08-22 | Sana Biotechnology, Inc. | Engineered cd47 proteins and uses thereof |
| WO2023173123A1 (en) | 2022-03-11 | 2023-09-14 | Sana Biotechnology, Inc. | Genetically modified cells and compositions and uses thereof |
| WO2023183313A1 (en) | 2022-03-22 | 2023-09-28 | Sana Biotechnology, Inc. | Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods |
| CN116804185A (zh) | 2022-03-25 | 2023-09-26 | 士泽生物医药（苏州）有限公司 | 一种通用型细胞及其制备方法 |
| KR20250008812A (ko) * | 2022-04-07 | 2025-01-15 | 페이트 세러퓨틱스, 인코포레이티드 | 동종 세포 치료에 사용하기 위한 면역 인식 경로에 관여하는 스텔스 전략 |
| CN114958768B (zh) * | 2022-06-02 | 2023-03-24 | 健颐生物科技发展(山东)有限公司 | Fgf10旁分泌通用型人成纤维细胞制剂的制备方法 |
| WO2024003349A1 (en) | 2022-07-01 | 2024-01-04 | Novo Nordisk A/S | Enhancing neuronal differentiation of ventral midbrain neural progenitor cells |
| WO2024030959A1 (en) | 2022-08-02 | 2024-02-08 | Sana Biotechnology, Inc. | Methods for differentiating cardiomyocytes |
| WO2024050349A2 (en) * | 2022-08-30 | 2024-03-07 | Emendobio Inc. | Strategies for knock-ins at b2m safe harbor sites |
| AU2023367765A1 (en) * | 2022-10-25 | 2025-03-20 | Wisconsin Alumni Research Foundation | Adhesion molecule inhibition for stem cell therapies |
| JP2025538841A (ja) * | 2022-12-12 | 2025-11-28 | プロレタリアート セラピューティクス， インコーポレイテッド | 心損傷を処置する方法 |
| GB202218755D0 (en) * | 2022-12-13 | 2023-01-25 | Replay Holdings Llc | Compositions and methods for non-immunogenicity |
| WO2024151541A1 (en) | 2023-01-09 | 2024-07-18 | Sana Biotechnology, Inc. | Type-1 diabetes autoimmune mouse |
| WO2024229302A1 (en) | 2023-05-03 | 2024-11-07 | Sana Biotechnology, Inc. | Methods of dosing and administration of engineered islet cells |
| WO2024243236A2 (en) | 2023-05-22 | 2024-11-28 | Sana Biotechnology, Inc. | Methods of delivery of islet cells and related methods |
| WO2025003393A1 (en) | 2023-06-30 | 2025-01-02 | Novo Nordisk A/S | Enhancing neuronal differentiation of neural progenitor cells |
| KR102740042B1 (ko) * | 2023-07-12 | 2024-12-06 | ㈜바이오솔빅스 | 인간 전분화능 줄기세포로 유래된 심장 오가노이드 제조방법, 효능 및 독성 평가 기술 |
| WO2025029810A1 (en) * | 2023-08-02 | 2025-02-06 | Fate Therapeutics, Inc. | Solid tumor targeting backbone promoting effector cell differentiation and function |
| WO2025043172A1 (en) | 2023-08-23 | 2025-02-27 | Sana Biotechnology, Inc. | Modified cd47 proteins and their uses |
| WO2025047921A1 (ja) * | 2023-09-01 | 2025-03-06 | 株式会社セル―ジョン | 拒絶反応に対する回避方法 |
| WO2025054202A1 (en) | 2023-09-05 | 2025-03-13 | Sana Biotechnology, Inc. | Method of screening a sample comprising a transgene with a unique barcode |
| WO2025075929A1 (en) * | 2023-10-02 | 2025-04-10 | Neurona Therapeutics Inc. | Methods of treating seizure activity |
| WO2025096757A1 (en) | 2023-11-01 | 2025-05-08 | Sana Biotechnology, Inc. | Hypoimmunogenic cd22-targeted car t cells for the treatment of relapsed and/or refractory b cell lymphomas |
| WO2025151838A1 (en) | 2024-01-12 | 2025-07-17 | Sana Biotechnology, Inc. | Safety switches to control in vitro and in vivo proliferation of cell therapy products |
| CN117919504B (zh) * | 2024-01-29 | 2024-12-20 | 山东第一医科大学附属省立医院(山东省立医院) | 一种ros响应微纳结构钛植入物纳米涂层及其制备方法与应用 |
| CN118345030B (zh) * | 2024-06-20 | 2024-08-16 | 羽铂精制生物技术(成都)有限公司 | iPSC诱导分化成为胰腺祖细胞修复胰腺的方法及应用 |
| CN119464205A (zh) * | 2025-01-16 | 2025-02-18 | 北京大学第三医院（北京大学第三临床医学院） | 干细胞来源的功能增强型间充质基质细胞及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1226233E (pt) * | 1999-08-05 | 2011-10-04 | Abt Holding Co | Células estaminais adultas multipotentes e métodos para isolamento |
| US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| WO2006071802A2 (en) * | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
| SI2477648T1 (sl) * | 2009-09-15 | 2022-09-30 | The Board Of Trustees Of The Leland Stanford Junior University | Sinergijska terapija proti CD47 za krvne rake |
| US20130108669A1 (en) * | 2010-04-16 | 2013-05-02 | The Mclean Hospital Corporation | Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereof |
| US9234176B2 (en) * | 2012-11-13 | 2016-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Chemically defined production of cardiomyocytes from pluripotent stem cells |
| AU2014248167B2 (en) * | 2013-04-03 | 2019-10-10 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
| KR101696874B1 (ko) * | 2013-07-31 | 2017-01-16 | 한국생명공학연구원 | 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법 |
| WO2015042356A1 (en) * | 2013-09-19 | 2015-03-26 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chemically defined culture medium for stem cell maintenance and differentiation |
| EP3261446A4 (en) * | 2015-02-26 | 2018-12-05 | The McLean Hospital Corporation | Methods and compositions for the treatment or prevention of parkinson's disease |
| AU2016261600B2 (en) * | 2015-05-08 | 2021-09-23 | President And Fellows Of Harvard College | Universal donor stem cells and related methods |
| PL3344758T3 (pl) * | 2015-09-01 | 2022-01-03 | Ncardia B.V. | Sposób in vitro różnicowania populacji ludzkich pluripotentnych komórek macierzystych w populację komórek kardiomiocytów |
| CN115806940A (zh) * | 2015-11-04 | 2023-03-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
| EP3568464A1 (en) * | 2017-01-13 | 2019-11-20 | The Regents of The University of California | Immunoengineered pluripotent cells |
| CN108048484B (zh) * | 2017-11-14 | 2021-07-06 | 海南一龄医疗产业发展有限公司 | 诱导性多能干细胞及其制备方法和应用 |
| EP3824074A4 (en) * | 2018-07-17 | 2022-04-20 | The Regents of The University of California | Cells differentiated from immunoengineered pluripotent cells |
| CN115768446A (zh) * | 2020-03-25 | 2023-03-07 | 萨那生物技术股份有限公司 | 用于治疗神经病症和疾患的低免疫原性神经细胞 |
-
2019
- 2019-07-17 EP EP19837257.5A patent/EP3824074A4/en active Pending
- 2019-07-17 CN CN201980056481.9A patent/CN112639079A/zh active Pending
- 2019-07-17 AU AU2019305585A patent/AU2019305585A1/en not_active Abandoned
- 2019-07-17 BR BR112021000637-0A patent/BR112021000637A2/pt unknown
- 2019-07-17 WO PCT/US2019/042117 patent/WO2020018615A2/en not_active Ceased
- 2019-07-17 KR KR1020217004402A patent/KR20210032454A/ko active Pending
- 2019-07-17 IL IL314721A patent/IL314721A/en unknown
- 2019-07-17 CA CA3109078A patent/CA3109078A1/en active Pending
- 2019-07-17 CN CN202411496724.XA patent/CN119372151A/zh active Pending
- 2019-07-17 SG SG11202100157YA patent/SG11202100157YA/en unknown
- 2019-07-17 MX MX2021000614A patent/MX2021000614A/es unknown
- 2019-07-17 US US17/260,224 patent/US20210292715A1/en not_active Abandoned
- 2019-07-17 JP JP2021502525A patent/JP2021530232A/ja active Pending
-
2020
- 2020-12-30 IL IL279871A patent/IL279871A/en unknown
-
2021
- 2021-01-15 MX MX2025004255A patent/MX2025004255A/es unknown
-
2024
- 2024-01-10 JP JP2024001947A patent/JP2024050597A/ja active Pending
-
2025
- 2025-01-09 US US19/015,552 patent/US20250283051A1/en active Pending
- 2025-08-28 AU AU2025223802A patent/AU2025223802A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024050597A5 (enExample) | ||
| US9861661B2 (en) | Elimination of immune responses to viral vectors | |
| JP4434479B2 (ja) | 標的の細胞および組織においてタンパク質を選択的に発現するための核酸配列および方法 | |
| JP2020518256A5 (enExample) | ||
| JP2022539496A (ja) | 安全な免疫ステルス細胞 | |
| EP2249864B1 (en) | Strategies to prevent and/or treat immune responses to soluble allofactors | |
| IL308706A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| JP2019088334A5 (enExample) | ||
| EP1369487A3 (en) | Recombinant vectors derived from adenovirus for use in gene therapy | |
| WO2003002155B1 (en) | Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies | |
| CA2074188A1 (en) | Vector with multiple tat activation response elements affecting gene expression | |
| JPH11502702A (ja) | 細胞培養方法 | |
| CN114752629A (zh) | 一种针对细胞中单个或多个基因进行基因编辑的方法、产品和应用 | |
| JPWO2021226151A5 (enExample) | ||
| CA2607214C (en) | Substances, compositions and methods for preventing and treating immune-mediated inflammatory disorders | |
| Rasmussen et al. | Endogenous retroviruses and multiple sclerosis | |
| CN113980113B (zh) | Kcnq4功能增强型突变体及其在治疗听力损失中的应用 | |
| CN120738154B (zh) | 一种低免疫原性的AsCas12a蛋白突变体及其应用 | |
| Limas | Enhanced myocardial RNA synthesis in spontaneously hypertensive rats Possible role of high-mobility group non-histone proteins | |
| JP2980889B2 (ja) | 肝実質細胞増殖因子 | |
| JPH1156382A (ja) | 肝実質細胞増殖因子をコードする遺伝子 | |
| WO2025026439A1 (zh) | 基因编辑系统及其应用 | |
| CN118685455A (zh) | 一种Ano3基因敲除的非人哺乳动物模型的构建方法及其应用 | |
| Mach et al. | MHC class I and class II | |
| CN119490995A (zh) | 肿瘤相关抗原的合成型核酸构建体设计以及工程t细胞制备 |